[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.]

[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Abstract Text:

Hirotaka Komaba,Masafumi Fukagawa,Hirotaka Komaba,Masafumi Fukagawa,

Successful kidney transplantation reverses mineral and bone disorder including secondary hyperparathyroidism, but persistent hyperparathyroidism with subsequent hypercalcemia emerges in a significant number of allograft patients. Among kidney-transplanted patients, approximately 5% will later require parathyroidectomy. Recently, the calcimimetic agent cinacalcet offers a novel therapeutic option to treat post-transplant hypercalcemia where parathyroidectomy might be considered. Despite persistent down-regulation of vitamin D receptor and calcium-sensing receptor in nodular hyperplasia even after successful kidney transplantation, calcimimetics has been shown to be efficacious in reducing serum calcium levels in such patients. However, there still remain several problems of calcimimetics, such as long-term efficacy, safety, optimal time point for cessation, and long-term effect on cardiovascular morbidity and allograft function after kidney transplantation. Furthermore, surgical in dication for persistent hyperparathyroidism is also a clinically important question. Further researches are needed to elucidate these issues.

[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Publishing Authors By Initials

H Komaba,M Fukagawa,H Komaba,M Fukagawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical calcium

VOLUME: 18

Page Numbers: 60-6

Journal Abbreviation:

ISSN: 0917-5857

DAY: 7

MONTH: Jan

YEAR: 2008

[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Information

Number of References:

LANGUAGE: jpn

NlmUniqueID: 9433326

[Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.]

AFFILIATION: Kobe University School of Medicine, Division of Nephrology and Kidney Center.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Calcium

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Basic and Clinical Aspects of Calcimimetics Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation Related Publications

• A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
• Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
• Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
• Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats.
• CENP-O Class Proteins Form a Stable Complex and Are Required for Proper Kinetochore Function.
• Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats.
• Dynamic behavior of Nuf2-Hec1 complex that localizes to the centrosome and centromere and is essential for mitotic progression in vertebrate cells.
• Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
• Protein and energy interactions throughout life. Metabolic basis and nutritional implications.
• Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
• Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.
• Serum Pro-hepcidin as an Indicator of Iron Status in Dialysis Patients.
• Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient.
• The kinetochore and spindle checkpoint in vertebrate cells.
• Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
• Whole or fragmentary information on parathyroid hormone?
• [Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.]
• [Basic and Clinical Aspects of Calcimimetics. Cinacalcet, effect and mechanisms of action.]
• [Basic and Clinical Aspects of Calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics.]
• [The metabolic syndrome and bone health. The Relationship Between Lipid and Glucose Metabolism and Bone Mineral Metabolism : Pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia.]